Pennant Investors’s Travere Therapeutics TVTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-55,800	Closed	-$459K	–	42
2024 Q2	$459K	Buy	+55,800	New	+$459K	0.12%	22
2024 Q1	–	Sell	-55,800	Closed	-$502K	–	45
2023 Q4	$502K	Buy	+55,800	New	+$502K	0.11%	18